Diagnostic Accuracy of [ ¹⁸ F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Metaanalysis.

Autor: Al-Ibraheem A; Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan; aibraheem@khcc.jo.; School of Medicine, University of Jordan, Amman, Jordan., Abdlkadir A; Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan., Herrmann K; Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany., Bomanji J; Institute of Nuclear Medicine, University College London, London, United Kingdom., Jadvar H; Division of Nuclear Medicine and Molecular Imaging, Keck School of Medicine, University of Southern California, Los Angeles, California., Shi H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China., Mansour A; Department of Radiology, King Hussein Cancer Center, Amman, Jordan., Paez D; Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria., Chiti A; Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy., Scott AM; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia; and.; Olivia Newton-John Cancer Research Institute and La Trobe University, Heidelberg, Victoria, Australia.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Oct 01; Vol. 65 (10), pp. 1533-1539. Date of Electronic Publication: 2024 Oct 01.

Bone mineral density in adult thalassaemias: a retrospective longitudinal study.

Autor: Algodayan S; Department of Imaging, Institute of Nuclear Medicine, University College London Hospital, London, UK.; Department of Radiology, Imam Abdulrahman Bin Faisal University Hospital, Dammam, Saudi Arabia., Balachandar R; Department of Imaging, Institute of Nuclear Medicine, University College London Hospital, London, UK., Papathanasiou N; Department of Nuclear Medicine, University Hospital of Patras, Patras, Greece., Bomanji J; Department of Imaging, Institute of Nuclear Medicine, University College London Hospital, London, UK., Porter JB; Department of Haematology, University College London Hospital., Waung J; Department of Haematology, University College London Hospital.; Department of Endocrinology, Whittington Hospital, London, UK.

Publikováno v: Nuclear medicine communications [Nucl Med Commun] 2024 Aug 01; Vol. 45 (8), pp. 658-665. Date of Electronic Publication: 2024 Jun 03.

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.

Autor: Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.; PET Committee of the German Society of Nuclear Medicine, Marburg, Germany., Eiber M; Department of Nuclear Medicine, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany., Beheshti M; Division of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria., Bomanji J; Institute of Nuclear Medicine, UCLH NHS Foundation Trust, London, UK., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Ceci F; Division of Nuclear Medicine and Theranostics, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Cho SY; Department of Radiology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Fanti S; IRCCS, AOU Bologna, Bologna, Italy., Giesel FL; Department of Nuclear Medicine, University Hospital Düsseldorf, Medical Faculty, Heinrich-Heine-University and Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Goffin K; Department of Nuclear Medicine, Division of Nuclear Medicine and Molecular Imaging, University Hospital Leuven, KU Leuven, Louvain, Belgium., Haberkorn U; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Jacene H; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, USA., Koo PJ; Banner MD Anderson Cancer Center, Phoenix, AZ, USA., Kopka K; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technical University Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany., Krause BJ; Department of Nuclear Medicine, University Medical Center, University of Rostock, Rostock, Germany., Lindenberg L; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA., Marcus C; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Emory University School of Medicine, Atlanta, GA, USA., Mottaghy FM; Department of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Osborne JR; Department of Radiology, Division of Molecular Imaging and Therapeutics, Weill Cornell Medicine, New York, NY, USA., Piert M; Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, University of Michigan, Ann Arbor, MI, USA., Rowe SP; Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Schöder H; Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Wan S; Institute of Nuclear Medicine, UCLH NHS Foundation Trust, London, UK., Wester HJ; Pharmaceutical Radiochemistry, Technische Universität München, Walther-Meißner-Str. 3, 85748, Garching, Germany., Hope TA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany. ken.herrmann@uk-essen.de.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Apr; Vol. 50 (5), pp. 1466-1486. Date of Electronic Publication: 2023 Jan 05.

Simultaneous 68Ga DOTATATE Positron Emission Tomography/Magnetic Resonance Imaging in Meningioma Target Contouring: Feasibility and Impact Upon Interobserver Variability Versus Positron Emission Tomography/Computed Tomography and Computed Tomography/Magnetic Resonance Imaging

Autor: Maclean, J. ^∗, Fersht, N., Sullivan, K., Kayani, I., Bomanji, J., Dickson, J., O'Meara, C., Short, S. ^†

Publikováno v: In Clinical Oncology July 2017 29(7):448-458

Defining the Target in Cancer of the Oesophagus: Direct Radiotherapy Planning with Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography

Autor: le Grange, F. ^∗, Wickers, S. ^∗, Warry, A. ^†, Warrilow, J. ^†, Bomanji, J. ^‡, Tobias, J.S. ^∗

Publikováno v: In Clinical Oncology March 2015 27(3):160-167